Preclinical News and Research

RSS
Aspirin does not improve survival among breast cancer patients with aggressive disease

Aspirin does not improve survival among breast cancer patients with aggressive disease

Bionomics plans to launch BNC210 Phase 2 trial for treatment of PTSD

Bionomics plans to launch BNC210 Phase 2 trial for treatment of PTSD

SRI Biosciences, SCI collaborate to develop novel compounds to treat multiple forms of cancer

SRI Biosciences, SCI collaborate to develop novel compounds to treat multiple forms of cancer

Existing compound offers hope for slowing Huntington's disease progression

Existing compound offers hope for slowing Huntington's disease progression

Researchers discover 'triple attack' technique to target liver cancer tumors

Researchers discover 'triple attack' technique to target liver cancer tumors

Cell Therapy Catapult’s 2015 Annual Review highlights key achievements across UK’s health and economy

Cell Therapy Catapult’s 2015 Annual Review highlights key achievements across UK’s health and economy

Heptares announces strategic drug discovery collaboration with Pfizer

Heptares announces strategic drug discovery collaboration with Pfizer

Can-Fite BioPharma reports financial results, provides updates on drug development programs

Can-Fite BioPharma reports financial results, provides updates on drug development programs

New combination approach to eradicate established tumors

New combination approach to eradicate established tumors

Novel anticancer agent appears to have greater potency, longer efficacy than irinotecan and topotecan

Novel anticancer agent appears to have greater potency, longer efficacy than irinotecan and topotecan

Key finding aids quest to produce liver cell therapies

Key finding aids quest to produce liver cell therapies

Researchers successfully combine antibody-drug conjugate with immunotherapy to attack breast cancer cells

Researchers successfully combine antibody-drug conjugate with immunotherapy to attack breast cancer cells

Allergan, Rugen Therapeutics collaborate to discover and develop novel therapies for ASD and OCD

Allergan, Rugen Therapeutics collaborate to discover and develop novel therapies for ASD and OCD

Mathematical models may help to predict risk of cancer spread following surgery

Mathematical models may help to predict risk of cancer spread following surgery

RPCI-led researchers identify strategies to prevent acute kidney injury

RPCI-led researchers identify strategies to prevent acute kidney injury

Experimental drug may stop life-threatening muscle wasting associated with advanced cancers

Experimental drug may stop life-threatening muscle wasting associated with advanced cancers

Crucial tumor-suppressing gene protects immune attack against lung cancer

Crucial tumor-suppressing gene protects immune attack against lung cancer

TSRI researchers awarded $1.6 million grant to advance preclinical studies of potential heroin vaccine

TSRI researchers awarded $1.6 million grant to advance preclinical studies of potential heroin vaccine

Urine-derived iPSCs model could help predict patient response to cholesterol-lowering drugs

Urine-derived iPSCs model could help predict patient response to cholesterol-lowering drugs

Hapten Sciences plans to initiate Phase 1 clinical trial for new poison ivy vaccine

Hapten Sciences plans to initiate Phase 1 clinical trial for new poison ivy vaccine

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.